Free readiness scan for Clinical Cancer Research.
Clinical cancer research: treatment outcomes, biomarkers, and translational trials
Upload your manuscript and see the first desk-rejection risks, journal-fit verdict, and top reviewer objections calibrated for Clinical Cancer Research in about 1-2 minutes.
Impact factor
10.2
Acceptance
~20-30%
First decision
~100-130 days median
Anthropic Privacy Partner
Zero-retention manuscript processing. Your manuscript is not used for training.
Start free preview
Get a fast submission-risk check
Calibrated on 5,000+ pre-submission reviews. Readiness, desk-screen risk, and the top blockers in 1-2 minutes.
Free manuscript scan · Full report from $39
What Clinical Cancer Research editors screen for
The signals Clinical Cancer Research rewards before the first reviewer
The readiness scan checks your manuscript against these first.
Clinical finding advancing cancer treatment or patient outcomes
Present research improving therapies, predicting response, or understanding outcomes. New treatment benefit? Better biomarker? Improved survival understanding? Show clinical significance.
Rigorous clinical data with adequate sample size and follow-up
Sufficient patient numbers for statistical power. Adequate follow-up for outcome maturation. Real clinical data or large retrospective studies.
Biomarker validation or mechanistic understanding of treatment response
Connect biomarkers to outcomes. Explain response mechanisms. Validation across independent cohorts strengthens biomarker papers.
Common Clinical Cancer Research rejection patterns
Named failure modes the scan looks for
These are patterns Clinical Cancer Research editors flag in initial triage. The free preview surfaces when your manuscript shows them.
Basic biology without direct clinical relevance or patient outcome data
CCR expects clinical relevance. Lab findings alone insufficient. How do results affect patients?
Small sample sizes or inadequate follow-up for clinical significance
Clinical studies require adequate power and follow-up. Small cohorts or short follow-up unconvincing.
Biomarker claims without independent validation
Biomarkers must validate in independent cohorts. Single-cohort discovery insufficient.
Common questions about Clinical Cancer Research submissions
Does the scan understand Clinical Cancer Research's editorial standards?
The readiness scan is calibrated to Clinical Cancer Research's scope and review signals. It estimates desk-rejection risk against known triage patterns, flags where your manuscript sits against journal fit, and surfaces the specific reviewer objections most likely to come up.
How long does the Clinical Cancer Research scan take?
The free preview takes about 1-2 minutes once you upload. If you want the Full Review with verified citations and section-by-section critique, it is delivered as a DOCX in about 30 minutes, after hundreds of parallel frontier-model LLM calls per review.
Is my manuscript safe?
Yes. Uploads are encrypted in transit, not used to train any AI model, and deleted after analysis. No human reads your manuscript on the AI path.
Where can I read more about Clinical Cancer Research?
See the full Clinical Cancer Research submission guide for scope details, insider tips, and acceptance-rate context. Or see how the Full Review works across all journals.
Find out before Clinical Cancer Research's editors do
Your reviewers will find these issues. The question is whether you find them first. Free preview in 1-2 minutes.
Start the free Clinical Cancer Research scan